{"transactions":[{"id":673189,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T20:39:14.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":185000,"price":7.44,"value":1376400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":17100,"source":{"system":"sec-edgar","filing":"0000950103-26-013201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326013201/ownership.xml","form_type":"4"}},{"id":740360,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:23:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000058","document":"wk-form4_1781299429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000058/wk-form4_1781299429.xml","form_type":"4"}},{"id":740359,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:23:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Kindler was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2537,"source":{"system":"sec-edgar","filing":"0001689548-26-000058","document":"wk-form4_1781299429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000058/wk-form4_1781299429.xml","form_type":"4"}},{"id":792250,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1697,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":34.6,"underlying":"Common Stock","underlying_shares":1697},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792249,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.05,"underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792248,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":10.72,"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792247,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28475,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":9.24,"underlying":"Common Stock","underlying_shares":28475},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792246,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":6.99,"underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792245,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4676,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":6.85,"underlying":"Common Stock","underlying_shares":4676},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792244,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10657,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":4.46,"underlying":"Common Stock","underlying_shares":10657},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792243,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":4.1,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":792242,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T21:04:08.000Z","date":"2026-05-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 24, 2026, Terns Pharmaceuticals, Inc. (the \"Issuer\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Merck Sharp & Dohme LLC (\"Merck\") and Thailand Merger Sub, Inc. (the \"Purchaser\"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the \"Merger Consideration\"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement), each option to purchase the Issuer's Shares that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Merger Consideration was cancelled and converted into the right to receive, without interest thereon and subject to the applicable withholding taxes, the excess of the Merger Consideration over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":1.82,"underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001174454-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000006/primarydocument.xml","form_type":"4"}},{"id":842132,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-16T21:07:27.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":71839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 13, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71839},"source":{"system":"sec-edgar","filing":"0000950103-26-003832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326003832/ownership.xml","form_type":"4"}},{"id":842131,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-16T21:07:27.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":71839,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":202100,"source":{"system":"sec-edgar","filing":"0000950103-26-003832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326003832/ownership.xml","form_type":"4"}},{"id":846693,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2026-03-12T20:27:40.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":41073,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41073,"derivative":{"exercise_price":3.51,"exercise_date":"2026-03-10","expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":41073},"source":{"system":"sec-edgar","filing":"0000950103-26-003688","document":"dp243216_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326003688/dp243216_4-kindler.xml","form_type":"4"}},{"id":846692,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:27:40.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":35612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 10, 2027."}],"balance_after":35612,"derivative":{"underlying":"Common Stock","underlying_shares":35612},"source":{"system":"sec-edgar","filing":"0000950103-26-003688","document":"dp243216_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326003688/dp243216_4-kindler.xml","form_type":"4"}},{"id":846691,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:27:40.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":19658,"price":3.51,"value":68999.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":130261,"source":{"system":"sec-edgar","filing":"0000950103-26-003688","document":"dp243216_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010326003688/dp243216_4-kindler.xml","form_type":"4"}},{"id":912499,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":224,"derivative":{"exercise_price":319.57,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":912498,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Kindler was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":912497,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Kindler was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":688,"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":925602,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:05:53.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":1697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $45,000 for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as to 1/12th of the total shares subject thereto on each monthly anniversary measured from January 1, 2026, such that 100% of the shares subject to the option will be fully vested on January 1, 2027."}],"balance_after":1697,"derivative":{"exercise_price":34.6,"expiration_date":"2036-01-31","underlying":"Common Stock","underlying_shares":1697},"source":{"system":"sec-edgar","filing":"0001174454-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000117445426000003/primarydocument.xml","form_type":"4"}},{"id":967986,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T21:16:54.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":235467,"price":3.6349,"value":855898.9983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.5000 to $3.7100, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":110603,"source":{"system":"sec-edgar","filing":"0000950103-25-016198","document":"dp238809_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325016198/dp238809_4-kindler.xml","form_type":"4"}},{"id":1029609,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:16:34.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":106837,"price":3.38,"value":361109.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.3500 to $3.4250, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":346070,"source":{"system":"sec-edgar","filing":"0000950103-25-012666","document":"dp235320_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325012666/dp235320_4-kindler.xml","form_type":"4"}},{"id":1029608,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:16:34.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":67523,"price":3.6,"value":243082.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.5700 to $3.6350, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":452907,"source":{"system":"sec-edgar","filing":"0000950103-25-012666","document":"dp235320_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325012666/dp235320_4-kindler.xml","form_type":"4"}},{"id":1113867,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T21:43:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant."}],"balance_after":45000,"derivative":{"exercise_price":4.1,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-25-004758","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218025004758/primarydocument.xml","form_type":"4"}},{"id":1145876,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:24.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":false,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-25-000073","document":"wk-form4_1747410736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536425000073/wk-form4_1747410736.xml","form_type":"4"}},{"id":1145875,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:24.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026."}],"balance_after":7305,"derivative":{"exercise_date":"2026-05-14","underlying":"Ordinary Shares","underlying_shares":7305},"source":{"system":"sec-edgar","filing":"0001585364-25-000073","document":"wk-form4_1747410736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536425000073/wk-form4_1747410736.xml","form_type":"4"}},{"id":1145874,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:24.000Z","date":"2025-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4754,"price":26.01,"value":123651.54,"ownership":{"direct":true},"balance_after":10559,"source":{"system":"sec-edgar","filing":"0001585364-25-000073","document":"wk-form4_1747410736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536425000073/wk-form4_1747410736.xml","form_type":"4"}},{"id":1145873,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:24.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":true,"shares":9904,"price":26.01,"value":257603.04,"ownership":{"direct":true},"balance_after":15313,"source":{"system":"sec-edgar","filing":"0001585364-25-000073","document":"wk-form4_1747410736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536425000073/wk-form4_1747410736.xml","form_type":"4"}},{"id":1204296,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2025-03-17T22:30:19.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":83517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":83517,"derivative":{"exercise_price":1.74,"exercise_date":"2025-03-13","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":83517},"source":{"system":"sec-edgar","filing":"0000950103-25-003516","document":"dp226399_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325003516/dp226399_4-kindler.xml","form_type":"4"}},{"id":1204295,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-17T22:30:19.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":false,"shares":87412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in full on March 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in full on March 14, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":87412},"source":{"system":"sec-edgar","filing":"0000950103-25-003516","document":"dp226399_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325003516/dp226399_4-kindler.xml","form_type":"4"}},{"id":1204294,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-17T22:30:19.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":71839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 13, 2026."}],"balance_after":71839,"derivative":{"underlying":"Common Stock","underlying_shares":71839},"source":{"system":"sec-edgar","filing":"0000950103-25-003516","document":"dp226399_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325003516/dp226399_4-kindler.xml","form_type":"4"}},{"id":1204293,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T22:30:19.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":true,"shares":87412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":520430,"source":{"system":"sec-edgar","filing":"0000950103-25-003516","document":"dp226399_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325003516/dp226399_4-kindler.xml","form_type":"4"}},{"id":1204292,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T22:30:19.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":39655,"price":1.74,"value":68999.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":433018,"source":{"system":"sec-edgar","filing":"0000950103-25-003516","document":"dp226399_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010325003516/dp226399_4-kindler.xml","form_type":"4"}},{"id":1287685,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T00:31:42.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":10657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $40,000 for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as to 1/12th of the total shares subject thereto on each monthly anniversary measured from January 1, 2025, such that 100% of the shares subject to the option will be fully vested on January 1, 2026."}],"balance_after":10657,"derivative":{"exercise_price":4.46,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":10657},"source":{"system":"sec-edgar","filing":"0001562180-25-000855","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218025000855/primarydocument.xml","form_type":"4"}},{"id":1337542,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-12-10T15:45:49.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":17598,"price":28.27,"value":497495.46,"ownership":{"direct":true},"balance_after":5409,"source":{"system":"sec-edgar","filing":"0001585364-24-000143","document":"wk-form4_1733845543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536424000143/wk-form4_1733845543.xml","form_type":"4"}},{"id":1463616,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-02T22:36:39.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":4676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $20,000 for the third and fourth quarters of 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest as to 1/6th of the total shares subject thereto on each monthly anniversary of the date of grant, such that 100% of the shares subject to the option will be fully vested on January 1, 2025."}],"balance_after":4676,"derivative":{"exercise_price":6.85,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":4676},"source":{"system":"sec-edgar","filing":"0001562180-24-005547","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218024005547/primarydocument.xml","form_type":"4"}},{"id":1479471,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:04:04.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant."}],"balance_after":32000,"derivative":{"exercise_price":6.99,"expiration_date":"2034-06-09","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001562180-24-005101","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218024005101/primarydocument.xml","form_type":"4"}},{"id":1514610,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:26:32.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-24-000082","document":"wk-form4_1715901982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536424000082/wk-form4_1715901982.xml","form_type":"4"}},{"id":1514609,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:26:32.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":9904,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-24-000082","document":"wk-form4_1715901982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536424000082/wk-form4_1715901982.xml","form_type":"4"}},{"id":1514608,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:26:32.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4207,"price":30.22,"value":127135.54,"ownership":{"direct":true},"balance_after":23007,"source":{"system":"sec-edgar","filing":"0001585364-24-000082","document":"wk-form4_1715901982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536424000082/wk-form4_1715901982.xml","form_type":"4"}},{"id":1514607,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:26:32.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":8764,"price":30.22,"value":264848.08,"ownership":{"direct":true},"balance_after":27214,"source":{"system":"sec-edgar","filing":"0001585364-24-000082","document":"wk-form4_1715901982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536424000082/wk-form4_1715901982.xml","form_type":"4"}},{"id":1572831,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2024-03-18T22:16:12.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":101626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101626,"derivative":{"exercise_price":1.43,"exercise_date":"2024-03-14","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":101626},"source":{"system":"sec-edgar","filing":"0000950103-24-003952","document":"dp208507_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010324003952/dp208507_4-kindler.xml","form_type":"4"}},{"id":1572830,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-18T22:16:12.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":87412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 14, 2025."}],"balance_after":87412,"derivative":{"underlying":"Common Stock","underlying_shares":87412},"source":{"system":"sec-edgar","filing":"0000950103-24-003952","document":"dp208507_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010324003952/dp208507_4-kindler.xml","form_type":"4"}},{"id":1572829,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-18T22:16:12.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":48251,"price":1.43,"value":68998.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $68,999."}],"balance_after":393363,"source":{"system":"sec-edgar","filing":"0000950103-24-003952","document":"dp208507_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010324003952/dp208507_4-kindler.xml","form_type":"4"}},{"id":1581849,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-12T23:50:01.000Z","date":"2024-03-09","kind":"exercise","planned":false,"acquired":false,"shares":106837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 9, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":106837},"source":{"system":"sec-edgar","filing":"0000950103-24-003742","document":"dp208302_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010324003742/dp208302_4-kindler.xml","form_type":"4"}},{"id":1581848,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T23:50:01.000Z","date":"2024-03-09","kind":"exercise","planned":false,"acquired":true,"shares":106837,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":345112,"source":{"system":"sec-edgar","filing":"0000950103-24-003742","document":"dp208302_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010324003742/dp208302_4-kindler.xml","form_type":"4"}},{"id":1698108,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-30T00:19:40.000Z","date":"2023-12-28","kind":"sale","planned":false,"acquired":false,"shares":96686,"price":1.41,"value":136327.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership (\"Parkview 2020\"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023."}],"balance_after":238275,"source":{"system":"sec-edgar","filing":"0000950103-23-018125","document":"dp204605_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323018125/dp204605_4-kindler.xml","form_type":"4"}},{"id":1856158,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T23:01:16.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant."}],"balance_after":32000,"derivative":{"exercise_price":12.05,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001562180-23-005167","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218023005167/primarydocument.xml","form_type":"4"}},{"id":1885141,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T18:39:06.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-23-000098","document":"wf-form4_168452153521332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536423000098/wf-form4_168452153521332.xml","form_type":"4"}},{"id":1885140,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:39:06.000Z","date":"2023-05-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3734,"price":32.86,"value":122699.24,"ownership":{"direct":true},"balance_after":18450,"source":{"system":"sec-edgar","filing":"0001585364-23-000098","document":"wf-form4_168452153521332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536423000098/wf-form4_168452153521332.xml","form_type":"4"}},{"id":1885139,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:39:06.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":7778,"price":32.86,"value":255585.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."}],"balance_after":22184,"source":{"system":"sec-edgar","filing":"0001585364-23-000098","document":"wf-form4_168452153521332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536423000098/wf-form4_168452153521332.xml","form_type":"4"}},{"id":1889617,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-17T19:40:40.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":8764,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-23-000074","document":"wf-form4_168435242824746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536423000074/wf-form4_168435242824746.xml","form_type":"4"}},{"id":1957080,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2023-03-13T21:04:37.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":125489,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125489,"derivative":{"exercise_price":1.17,"exercise_date":"2023-03-09","expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":125489},"source":{"system":"sec-edgar","filing":"0000950103-23-004009","document":"dp190524_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323004009/dp190524_4-kindler.xml","form_type":"4"}},{"id":1957079,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-03-13T21:04:37.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":106837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested in full on March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested in full on March 9, 2024."}],"balance_after":106837,"derivative":{"underlying":"Common Stock","underlying_shares":106837},"source":{"system":"sec-edgar","filing":"0000950103-23-004009","document":"dp190524_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323004009/dp190524_4-kindler.xml","form_type":"4"}},{"id":1957078,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-13T21:04:37.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":58974,"price":1.17,"value":68999.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":334961,"source":{"system":"sec-edgar","filing":"0000950103-23-004009","document":"dp190524_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323004009/dp190524_4-kindler.xml","form_type":"4"}},{"id":1993708,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-25T01:12:40.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":61576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61576},"source":{"system":"sec-edgar","filing":"0000950103-23-003032","document":"dp189563_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323003032/dp189563_4-kindler.xml","form_type":"4"}},{"id":1993707,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-25T01:12:40.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":61576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":275987,"source":{"system":"sec-edgar","filing":"0000950103-23-003032","document":"dp189563_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010323003032/dp189563_4-kindler.xml","form_type":"4"}},{"id":2185832,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T22:28:13.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":50000,"price":2.3,"value":115000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.3000 to $2.3250, inclusive. The reporting person undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above."}],"balance_after":214411,"source":{"system":"sec-edgar","filing":"0000950103-22-014033","document":"dp178706_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322014033/dp178706_4-kindler.xml","form_type":"4"}},{"id":2225825,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T01:00:05.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant."}],"balance_after":32000,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001562180-22-005264","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218022005264/primarydocument.xml","form_type":"4"}},{"id":2264102,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:52:30.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-22-000051","document":"wf-form4_165298273556605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536422000051/wf-form4_165298273556605.xml","form_type":"4"}},{"id":2264101,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:52:30.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":7778,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-22-000051","document":"wf-form4_165298273556605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536422000051/wf-form4_165298273556605.xml","form_type":"4"}},{"id":2264100,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:52:30.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":3168,"price":38.57,"value":122189.76,"ownership":{"direct":true},"balance_after":14406,"source":{"system":"sec-edgar","filing":"0001585364-22-000051","document":"wf-form4_165298273556605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536422000051/wf-form4_165298273556605.xml","form_type":"4"}},{"id":2264099,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:52:30.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":6599,"price":38.57,"value":254523.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."}],"balance_after":17574,"source":{"system":"sec-edgar","filing":"0001585364-22-000051","document":"wf-form4_165298273556605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536422000051/wf-form4_165298273556605.xml","form_type":"4"}},{"id":2315597,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-29T21:07:11.000Z","date":"2022-03-25","kind":"exercise","acquired":false,"shares":16212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 25, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16212},"source":{"system":"sec-edgar","filing":"0000950103-22-005409","document":"dp170035_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322005409/dp170035_4-kindler.xml","form_type":"4"}},{"id":2315596,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-29T21:07:11.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":16212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":264411,"source":{"system":"sec-edgar","filing":"0000950103-22-005409","document":"dp170035_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322005409/dp170035_4-kindler.xml","form_type":"4"}},{"id":2375241,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2022-02-24T22:44:14.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":83189,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":83189,"derivative":{"exercise_price":2.03,"exercise_date":"2022-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":83189},"source":{"system":"sec-edgar","filing":"0000950103-22-003218","document":"dp167778_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322003218/dp167778_4-kindler.xml","form_type":"4"}},{"id":2375240,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-24T22:44:14.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":61576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on February 22, 2023."}],"balance_after":61576,"derivative":{"underlying":"Common Stock","underlying_shares":61576},"source":{"system":"sec-edgar","filing":"0000950103-22-003218","document":"dp167778_4-kindler.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322003218/dp167778_4-kindler.xml","form_type":"4"}},{"id":2375239,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T22:44:14.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":33990,"price":2.03,"value":68999.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":248199,"source":{"system":"sec-edgar","filing":"0000950103-22-003218","document":"dp167778_4-kindler.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000095010322003218/dp167778_4-kindler.xml","form_type":"4"}},{"id":2481001,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-08T21:39:34.000Z","date":"2021-12-08","kind":"disposition_to_issuer","acquired":false,"shares":18500,"price":47.5,"value":878750.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation (\"Buyer\"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer (\"Merger Sub\"), dated as of April 15, 2021 (the \"Merger Agreement\"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 2,164 shares of common stock subject to a restricted stock unit grant (the \"RSUs\") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-21-028111","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000143774921028111/rdgdoc.xml","form_type":"4"}},{"id":2481000,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-08T21:39:34.000Z","date":"2021-12-08","kind":"disposition_to_issuer","acquired":false,"shares":99487,"price":47.5,"value":4725632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation (\"Buyer\"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer (\"Merger Sub\"), dated as of April 15, 2021 (the \"Merger Agreement\"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 2,164 shares of common stock subject to a restricted stock unit grant (the \"RSUs\") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 2,164 shares of common stock subject to a restricted stock unit grant (the \"RSUs\") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-21-028111","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000143774921028111/rdgdoc.xml","form_type":"4"}},{"id":2555962,"issuer":{"id":49595,"kind":"organization","name":"Terns Pharmaceuticals, Inc.","symbol":"TERN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-01T01:17:08.000Z","date":"2021-09-28","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares subject to the option vest on the first anniversary measured from September 28, 2021 (the \"Vesting Commencement Date\"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":22000,"derivative":{"exercise_price":10.72,"expiration_date":"2031-09-28","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-21-038548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000089924321038548/doc4.xml","form_type":"4"}},{"id":2705831,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-19T16:59:06.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."}],"balance_after":6599,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-21-000084","document":"wf-form4_162144352984780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536421000084/wf-form4_162144352984780.xml","form_type":"4"}},{"id":2718943,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:57:17.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":5804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5804},"source":{"system":"sec-edgar","filing":"0001585364-21-000060","document":"wf-form4_162075941792053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536421000060/wf-form4_162075941792053.xml","form_type":"4"}},{"id":2718942,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:57:17.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":2786,"price":42.96,"value":119686.56,"ownership":{"direct":true},"balance_after":10975,"source":{"system":"sec-edgar","filing":"0001585364-21-000060","document":"wf-form4_162075941792053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536421000060/wf-form4_162075941792053.xml","form_type":"4"}},{"id":2718941,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:57:17.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":5804,"price":42.96,"value":249339.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."}],"balance_after":13761,"source":{"system":"sec-edgar","filing":"0001585364-21-000060","document":"wf-form4_162075941792053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536421000060/wf-form4_162075941792053.xml","form_type":"4"}},{"id":2738686,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T20:13:26.000Z","date":"2021-04-23","kind":"grant","acquired":true,"shares":2164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which will vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date."}],"balance_after":99487,"source":{"system":"sec-edgar","filing":"0001628280-21-007732","document":"wf-form4_161955435895015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000162828021007732/wf-form4_161955435895015.xml","form_type":"4"}},{"id":2769541,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2021-03-29T23:47:20.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":22107,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22107,"derivative":{"exercise_price":7.71,"exercise_date":"2021-03-25","expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":22107},"source":{"system":"sec-edgar","filing":"0001123292-21-000566","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329221000566/edgar.xml","form_type":"4"}},{"id":2769540,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-29T23:47:20.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":16212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full on March 25, 2022."}],"balance_after":16212,"derivative":{"underlying":"Common Stock","underlying_shares":16212},"source":{"system":"sec-edgar","filing":"0001123292-21-000566","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329221000566/edgar.xml","form_type":"4"}},{"id":2769539,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-29T23:47:20.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":8949,"price":7.71,"value":68996.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":214209,"source":{"system":"sec-edgar","filing":"0001123292-21-000566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329221000566/edgar.xml","form_type":"4"}},{"id":2786694,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-16T20:34:46.000Z","date":"2021-03-13","kind":"exercise","acquired":false,"shares":62189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 13, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":62189},"source":{"system":"sec-edgar","filing":"0001123292-21-000486","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329221000486/edgar.xml","form_type":"4"}},{"id":2786693,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:34:46.000Z","date":"2021-03-13","kind":"exercise","acquired":true,"shares":62189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen, Inc. common stock."}],"balance_after":205260,"source":{"system":"sec-edgar","filing":"0001123292-21-000486","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329221000486/edgar.xml","form_type":"4"}},{"id":2863881,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T21:15:20.000Z","date":"2020-12-02","kind":"gift","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer to a family trust for estate planning purposes."}],"balance_after":18500,"source":{"system":"sec-edgar","filing":"0000899243-21-006290","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000089924321006290/doc5.xml","form_type":"5"}},{"id":2863880,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T21:15:20.000Z","date":"2020-12-02","kind":"gift","acquired":false,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer to a family trust for estate planning purposes."}],"balance_after":97323,"source":{"system":"sec-edgar","filing":"0000899243-21-006290","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000089924321006290/doc5.xml","form_type":"5"}},{"id":3110773,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2020-06-15T20:26:02.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":2.65,"value":39750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly equal installments over the three year period beginning on June 11, 2020."}],"balance_after":78121,"derivative":{"exercise_price":2.65,"expiration_date":"2030-06-11","underlying":"Class A common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-20-004482","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218020004482/primarydocument.xml","form_type":"4"}},{"id":3137911,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-05-22T20:41:02.000Z","date":"2020-05-21","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of SIGA Technologies, Inc. on a one for one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on May 21, 2019, and vested on the first anniversary of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on May 21, 2019, and vested on the first anniversary of such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-20-012324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036120012324/form4.xml","form_type":"4"}},{"id":3137910,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true}}],"security":"Common Stock, Par Value $.0001 Per Share","published_at":"2020-05-22T20:41:02.000Z","date":"2020-05-21","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":127339,"source":{"system":"sec-edgar","filing":"0001140361-20-012324","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036120012324/form4.xml","form_type":"4"}},{"id":3143108,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-20T00:39:49.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":6054,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-15","expiration_date":"2020-05-15","underlying":"Ordinary Shares","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001585364-20-000061","document":"wf-form4_158993517190025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536420000061/wf-form4_158993517190025.xml","form_type":"4"}},{"id":3143107,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-20T00:39:49.000Z","date":"2020-05-15","kind":"tax_withholding","acquired":false,"shares":2906,"price":52.76,"value":153320.56,"ownership":{"direct":true},"balance_after":7957,"source":{"system":"sec-edgar","filing":"0001585364-20-000061","document":"wf-form4_158993517190025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536420000061/wf-form4_158993517190025.xml","form_type":"4"}},{"id":3143106,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-20T00:39:49.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":6054,"price":52.76,"value":319409.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2019."}],"balance_after":10863,"source":{"system":"sec-edgar","filing":"0001585364-20-000061","document":"wf-form4_158993517190025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536420000061/wf-form4_158993517190025.xml","form_type":"4"}},{"id":3147503,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-05-15T20:49:53.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":3728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which will vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date."}],"balance_after":115823,"source":{"system":"sec-edgar","filing":"0000899243-20-013239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000089924320013239/doc4.xml","form_type":"4"}},{"id":3154761,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-11T20:56:34.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":5804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."}],"balance_after":5804,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5804},"source":{"system":"sec-edgar","filing":"0001585364-20-000055","document":"wf-form4_158923057614804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000158536420000055/wf-form4_158923057614804.xml","form_type":"4"}},{"id":3205757,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2020-03-17T22:32:57.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":96324,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96324,"derivative":{"exercise_price":2.01,"exercise_date":"2020-03-13","expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":96324},"source":{"system":"sec-edgar","filing":"0001123292-20-000569","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329220000569/edgar.xml","form_type":"4"}},{"id":3205756,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-17T22:32:57.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":62189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full on March 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full on March 13, 2021."}],"balance_after":62189,"derivative":{"underlying":"Common Stock","underlying_shares":62189},"source":{"system":"sec-edgar","filing":"0001123292-20-000569","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329220000569/edgar.xml","form_type":"4"}},{"id":3205755,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T22:32:57.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":34328,"price":2.01,"value":68999.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $69,000."}],"balance_after":143071,"source":{"system":"sec-edgar","filing":"0001123292-20-000569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329220000569/edgar.xml","form_type":"4"}},{"id":3216110,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-11T20:12:06.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of vTv Therapeutics Inc. Class A Common Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on March 10, 2017 and vest in three equal installments beginning March 10, 2018."}],"balance_after":0,"derivative":{"expiration_date":"2020-03-10","underlying":"Class A Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001562180-20-002397","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218020002397/primarydocument.xml","form_type":"4"}},{"id":3216109,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-03-11T20:12:06.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock issued upon vesting of 33.33% of the restricted stock units granted March 10, 2017."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001562180-20-002397","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000156218020002397/primarydocument.xml","form_type":"4"}},{"id":3218088,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-10T20:17:48.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":24703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on March 8, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on March 8, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24703},"source":{"system":"sec-edgar","filing":"0001123292-20-000536","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329220000536/edgar.xml","form_type":"4"}},{"id":3218087,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:17:48.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":24703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":108743,"source":{"system":"sec-edgar","filing":"0001123292-20-000536","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000112329220000536/edgar.xml","form_type":"4"}},{"id":3277403,"issuer":{"id":15247,"kind":"organization","name":"PPD, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-02-12T21:17:54.000Z","date":"2020-02-10","kind":"purchase","acquired":true,"shares":18500,"price":27,"value":499500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were acquired in a directed share program in connection with the Issuer's initial public offering."}],"balance_after":112095,"source":{"system":"sec-edgar","filing":"0000899243-20-004253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000089924320004253/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-12T21:17:54.000000Z,3277403"}